Learn About Budd-Chiari Syndrome

What is the definition of Budd-Chiari Syndrome?
Budd-Chiari syndrome is a rare disorder characterized by obstruction of the veins of the liver that carry the blood flow from the liver. When the blood flow out of the liver is impeded, blood backs up in the liver, causing it to enlarge (hepatomegaly). The spleen may also enlarge (splenomegaly). This backup of blood increases blood pressure in the portal vein, which carries blood to the liver from the intestines (portal hypertension), and result in dilated, twisted veins in the esophagus (esophageal varices). Portal hypertension, leads to fluid accumulating in the abdomen (called ascites). The clot may extend to also block the inferior vena cava (the large vein that carries blood from the lower parts of the body to the heart). Varicose veins in the abdomen near the skin's surface may develop and become visible. In some cases, scarring of the liver (cirrhosis) occurs. Other symptoms may include fatigue, abdominal pain, nausea, jaundice and bleeding in the esophagus. The severity of the disorder varies from case to case, depending on the site and number of affected veins. It most often occurs in patients which have a disorder that makes blood more likely to clot, such as those who are pregnant or who have a tumor, a chronic inflammatory disease, a clotting disorder, an infection, or a myeloproliferative disorder. In about one third of the cases, the cause of Budd-Chiari syndrome is unknown.
Save information for later
Sign Up
What are the alternative names for Budd-Chiari Syndrome?
  • Budd-Chiari syndrome
  • Membranous obstruction of the inferior vena cava
Who are the top Budd-Chiari Syndrome Local Doctors?
Learn about our expert tiers
Learn more
What are the latest Budd-Chiari Syndrome Clinical Trials?
Vienna Vascular Liver Disease Study: Characterization of Patients With Vascular Liver Disease - a Registry With Biobank

Summary: The aim of this Register Trial is to systematically study the epidemiology, risk factors, liver function as well prognosis of patients with vascular liver diseases. Furthermore, important clinical parameters will be assessed in order to evaluate patients' coagulation status and in order to develop new biomarkers derived from blood, urine, stool or ascites of patients as well as histological sample...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Multicenter, Randomized, Open-label Study Evaluating the Efficacy and Safety of Hepatic Resection for Hepatocellular Carcinoma With Venous Tumor Thrombosis After Initial Atezolizumab Plus Bevacizumab Treatment

Summary: The treatment strategies for HCC with PVTT is still controversial, and differ substantially between the west and the east. According to western guidelines, including those of the EASL, BCLC, and AASLD, PVTT is regarded as a contra-indication to initial surgery or transarterial chemoembolization. At present, there is still no consensus on the diagnosis and treatment standards of HCC with HVTT/IVCTT...

Who are the sources who wrote this article ?

Published Date: May 06, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Budd-Chiari Syndrome?
Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis.
Living Donor Liver Transplantation for Budd-Chiari Syndrome: A Propensity Score-Matched Analysis.
Tired of the same old research?
Check Latest Advances
Percutaneous transluminal angioplasty for symptomatic hepatic vein-type Budd-Chiari syndrome: feasibility and long-term outcomes.